Wealthspire Advisors (Maryland)’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-326
| Closed | -$11K | – | 1863 |
|
2019
Q1 | $11K | Buy |
326
+45
| +16% | +$1.52K | ﹤0.01% | 1502 |
|
2018
Q4 | $9K | Sell |
281
-32
| -10% | -$1.03K | ﹤0.01% | 1515 |
|
2018
Q3 | $16K | Sell |
313
-22
| -7% | -$1.13K | ﹤0.01% | 1390 |
|
2018
Q2 | $20K | Buy |
335
+22
| +7% | +$1.31K | ﹤0.01% | 1316 |
|
2018
Q1 | $14K | Buy |
313
+37
| +13% | +$1.66K | ﹤0.01% | 1436 |
|
2017
Q4 | $11K | Buy |
276
+83
| +43% | +$3.31K | ﹤0.01% | 1560 |
|
2017
Q3 | $8K | Buy |
193
+8
| +4% | +$332 | ﹤0.01% | 1659 |
|
2017
Q2 | $8K | Buy |
+185
| New | +$8K | ﹤0.01% | 1628 |
|